Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 5.752.905.004.895.34

What is the latest EV/Core EBITDA ratio of VENUS REMEDIES ?

The latest EV/Core EBITDA ratio of VENUS REMEDIES is 5.75 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20245.75
Mar20232.90
Mar20225.00
Mar20214.89
Mar20205.34

How is EV/Core EBITDA of VENUS REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 5.75
98.28
Mar2023 2.9
-42.00
Mar2022 5
2.25
Mar2021 4.89
-8.43
Mar2020 5.34 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/Core EBITDA ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹410.9 Cr 5.3% -10.7% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,478.0 Cr -1.3% -4.8% 45% Stock Analytics
DIVIS LABORATORIES ₹163,822.0 Cr 0.5% 6.4% 58.2% Stock Analytics
CIPLA ₹123,920.0 Cr 2.1% 3.8% 24.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,322.0 Cr -0.6% -5.7% 5.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,217.3 Cr 0.1% -3.6% 48.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

5.3%

-10.7%

-19.6%

SENSEX

0.9%

-0.3%

20.9%


You may also like the below Video Courses